Even with long-term preventive treatment, many people with hereditary angioedema still sometimes have swelling attacks that require on-demand treatment, a review study finds.
Articles by Marisa Wexler, MS
The design of an ongoing Phase 3 clinical trial testing sebetralstat as an on-demand oral treatment for swelling attacks…
Up to one year of treatment with Takhzyro (lanadelumab) significantly reduced rates of swelling attacks and improved quality of…
New treatments for hereditary angioedema (HAE) have been life-changing for people in the U.K., but more and better efforts…
Treatment with Orladeyo (berotralstat) effectively prevented swelling and improved life quality for three people with hereditary angioedema (HAE)…
Preventive treatment with Takhzyro (lanadelumab) reduced the rate of swelling attacks and improved life quality for Japanese patients with…
The U.S. Food and Drug Administration (FDA) has approved a new generic version of Firazyr (icatibant injection) for…
People with hereditary angioedema (HAE) are able to recognize early signs of swelling attacks and the need to get…
BioCryst Pharmaceuticals is teaming up with Er-Kim Pharmaceuticals to commercialize Orladeyo (berotralstat) in Turkey. Orladeyo is an oral…
A woman still doesn’t have a definitive answer as to the underlying cause of her angioedema after more than…